DEMITRACK MARK (Sr VP & Chief Medical Officer) received a stock award from TREVENA INC
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 2 awards
Filed: 12/15/2023ACC: 0001062993-23-022688
Officer· Sr VP & Chief Medical Officer
Since Dec 2018
+231.41K
Net shares
Net buyer
$2.2K
Total sold
0
Open market trades
0B · 0S
3
Total transactions
235K acquired · 3.59K disposed
Non-Derivative Transactions3
Common Stock
Direct
Shares
+185K
Price / share
$0.61
Trade value
$112.85K
% of position
247.3%
12/14/2023
74.82K→259.82K
Common Stock
Direct
Shares
+50K
Price / share
$0.61
Trade value
$30.50K
% of position
19.2%
12/14/2023
259.82K→309.82K
Common Stock
Direct
Shares
−3.59K
Price / share
$0.61
Trade value
$2.19K
% of position
1.2%
12/14/2023
309.82K→306.22K
Total
Net shares
+231.41K
Net value
$141.16K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 12/14/2023 | A · Award | +185K | $0.61 | $112.85K | 247.3% | 74.82K | 259.82K |
| Common Stock Direct | 12/14/2023 | A · Award | +50K | $0.61 | $30.50K | 19.2% | 259.82K | 309.82K |
| Common Stock Direct | 12/14/2023 | F · Tax Withholding | −3.59K | $0.61 | $2.19K | 1.2% | 309.82K | 306.22K |
| Total | +231.41K | $141.16K | ||||||
Derivative Transactions0
No derivative transactions reported